Stevanato Group S.P.A. (STVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | STVN | CORT | CRNX | ||
| Company | Stevanato Group S.P.A. | Corcept Therapeutics | Crinetics Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 14.75 | 43.76 | 39.63 | ||
| High | 14.88 | 44.42 | 40.03 | ||
| Low | 14.62 | 43.27 | 38.99 | ||
| Latest | 14.74 | 43.90 | 39.77 | ||
| Change | -0.03 | +0.22 | +0.02 | ||
| % Change | -0.20% | +0.50% | +0.05% | ||
| Volume | 279,700 | 840,700 | 739,800 | ||
| 20-Day Average Volume | 662,295 | 2,028,535 | 1,207,000 | ||
| Previous Close | 14.77 | 43.68 | 39.75 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.09 | 39.42 | 37.03 | ||
| 20-Day Raw Stochastic | 69.55% | 63.32% | 90.87% | ||
| 20-Day Relative Strength | 48.82 | 59.89 | 51.17 | ||
| Weighted Alpha | -39.52 | +10.78 | +9.25 | ||
| Today's Opinion | 88% Sell | 40% Sell | 64% Sell | ||
| Previous Opinion | 88% Sell | 40% Sell | 48% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.89% since 04/08/26 | +4.85% since 04/08/26 | -0.48% since 04/08/26 | ||
| Low | 13.39 on 04/10/26 | 41.00 on 04/09/26 | 38.25 on 04/13/26 | ||
| High | 15.11 on 04/14/26 | 44.42 on 04/15/26 | 40.44 on 04/14/26 | ||
| 1-Month | |||||
| %Chg | -1.67% since 03/13/26 | +36.55% since 03/13/26 | +6.08% since 03/13/26 | ||
| Low | 12.89 on 03/27/26 | 32.04 on 03/16/26 | 33.10 on 03/30/26 | ||
| High | 15.74 on 03/17/26 | 50.40 on 03/25/26 | 40.44 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | -29.81% since 01/15/26 | +24.05% since 01/15/26 | -29.52% since 01/15/26 | ||
| Low | 12.89 on 03/27/26 | 28.66 on 02/19/26 | 33.10 on 03/30/26 | ||
| High | 21.16 on 01/16/26 | 50.40 on 03/25/26 | 56.99 on 01/21/26 | ||
| 6-Month | |||||
| %Chg | -38.40% since 10/15/25 | -42.85% since 10/15/25 | -9.92% since 10/15/25 | ||
| Low | 12.89 on 03/27/26 | 28.66 on 02/19/26 | 33.10 on 03/30/26 | ||
| High | 27.99 on 10/24/25 | 89.00 on 12/15/25 | 57.99 on 01/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,472,991 | 4,646,416 | 4,162,024 | ||
| Shares Outstanding, K | 302,843 | 106,374 | 104,705 | ||
| Annual Sales | 1,342,160,000 | 761,410,000 | 7,700,000 | ||
| Annual Net Income | 158,210,000 | 99,650,000 | -465,320,000 | ||
| Last Quarter Sales | 399,570,000 | 202,130,000 | 6,160,000 | ||
| Last Quarter Net Income | 54,410,000 | 24,290,000 | -122,820,000 | ||
| 60-Month Beta | 0.62 | 0.25 | 0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.21 on 03/04/26 | 0.20 on 02/24/26 | -1.29 on 02/26/26 | ||
| Latest Earnings Date | 05/14/26 | 05/04/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.02 | 52.80 | 0.00 | ||